Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
03/2005
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872838 Derivatives of water insoluble drugs which exhibit good activity and water solubility
03/29/2005US6872833 Alzheimer's disease; Parkinson's disease; antidepressants
03/29/2005US6872829 Reacting parent compound with alcohols or acid in presence of cerium ammonium nitrate
03/29/2005US6872746 Isomeric fused pyrrolocarbazoles and isoindolones
03/29/2005US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/29/2005US6872718 Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents
03/29/2005US6872715 Anticancer agents; antiproliferative agent; 17-(N,N-bis(hydroxyethyl)aminoethylamino)-or 17-(cyclopropylmethylamino)-geldanamycin derivatives
03/29/2005CA2260213C Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
03/24/2005WO2005026171A1 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d¸6,5-d']dipyrimidyne and 10-aza-analogue thereof
03/24/2005WO2005026159A1 Benzoxazole acetonitriles
03/24/2005WO2005026126A1 Crf antagonists and heterobicyclic compounds
03/24/2005WO2005025507A2 Dihydropyridine compounds for treating or preventing metabolic disorders
03/24/2005WO2004106293A3 Oxazolyl - and thiazolyl - purine based tricyclic compounds.
03/24/2005WO2004100947A3 Novel chemical compounds
03/24/2005WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
03/24/2005US20050065338 Total synthesis of galanthamine, analogues and derivatives thereof
03/24/2005US20050065305 Superior in hole injecting property, making it unnecessary to add a strongly acidic dopant for enhancing hole injecting property; may be useful in flat panel display devices
03/24/2005US20050065179 Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments
03/24/2005CA2538188A1 Dihydropyridine compounds for treating or preventing metabolic disorders
03/24/2005CA2538026A1 Crf antagonists and heterobicyclic compounds
03/23/2005EP1516872A1 Novel azasugar derivative and drug containing the same as the active ingredient
03/23/2005EP1515974A2 Novel maxi-k channel blockers, methods of use and process for making the same
03/23/2005EP1515969A1 Spiroindolinepiperidine derivatives
03/23/2005EP1515965A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
03/23/2005CN1597683A 7-position oxygen and nitrogen contained substituted camptothecin derirative and its synthesis method
03/23/2005CN1193756C SGK2 and SGK3 used as diagnostic and therapeutic targets
03/22/2005US6870055 Heterocyclic amides such as 3-dimethylaminomethyl-6-methoxy-2 -methyl-4-phenyl-2H-isoquinoline-1-one, used as antiarrhythmic agents
03/22/2005US6869971 UCS1025 derivatives
03/22/2005US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine)
03/22/2005US6869949 Such as 8-hydroxy-2,3-dimiethyl-9-(3-thienyl)-7,8,9,10-tetrahydroimidazo(1,2 -h)(1,7)napththyridin-7-one
03/22/2005US6869943 Sorbitol dehydrogenase inhibitors
03/17/2005WO2005023818A2 Heterobicyclic compounds as pharmaceutically active agents
03/17/2005WO2005007652A3 Substituted quinolin-4-ylamine analogues
03/17/2005WO2004103305A3 Spiropyrazole compound
03/17/2005WO2004100897A3 Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059687 Modulators of ATP-Binding Cassette transporters
03/17/2005US20050059679 Novel hexacyclic compounds
03/17/2005US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
03/17/2005CA2572750A1 Heterobicyclic compounds as pharmaceutically active agents
03/16/2005EP1514552A1 Novel fused imidazole derivative
03/16/2005EP1514267A2 Optical storage media comprising pentacyclic xanthylium dyes
03/16/2005EP1513521A2 Pyranoindazoles and their use for the treatment of glaucoma
03/16/2005EP1425283B1 Novel 4-aminofuropyrimidines and the use thereof
03/16/2005EP1203091B1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases
03/16/2005EP0869966B1 Prodrugs of thrombin inhibitors
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1594318A Linked piperidine hydroxycamptothecin, its salts and its salts (0-10) hydrate, and preparation and preparing process thereof
03/15/2005US6867334 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743
03/15/2005US6867215 Cardioprotective phosphonates and malonates
03/15/2005CA2146852C New substituted pyrazole derivatives, processes for their preparation and their use as herbicides
03/10/2005WO2005021538A1 Novel chelating agents and chelates and their use
03/10/2005WO2005021529A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005WO2005021515A2 Inhibitors of phosphodiesterase type-iv
03/10/2005WO2005020914A2 Pyridomorphinans, pyridazinomorphinans and use thereof
03/10/2005WO2005020911A2 Benzo[1, 3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and using the same
03/10/2005WO2005020894A2 Rifamycin analogs and uses thereof
03/10/2005WO2004096795A3 C-fms kinase inhibitors
03/10/2005WO2002080150A8 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness
03/10/2005US20050054857 Synthesis of pyrroles
03/10/2005US20050054678 Nitrogenous five-membered ring compounds
03/10/2005US20050054657 Induce immunology response; anticancer agents
03/10/2005US20050054634 Azepinoindole derivatives as pharmaceutical agents
03/10/2005CA2537185A1 Inhibitors of phosphodiesterase type-iv
03/10/2005CA2537141A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
03/10/2005CA2536783A1 Novel chelating agents and chelates and their use
03/10/2005CA2536378A1 Rifamycin analogs and uses thereof
03/10/2005CA2531768A1 Chrna2 genetic markers associated with galantamine response
03/09/2005EP1511752A2 Camptothecins with a modified lactone ring
03/09/2005EP1511732A1 Process for the manufacture of quinoline derivatives
03/09/2005EP1057814B1 Tetrahydrobenzindole derivatives
03/09/2005EP0839149B9 Galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives
03/09/2005CN1592749A Intermediates for preparing glycogen phosphorylase inhibitors
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592740A Process for the synthesis of amine ethers from secondary amino oxides and its use
03/09/2005CN1592619A Pyranoindazoles and their use for the treatment of glaucoma
03/09/2005CN1590372A Arylphenyl-substituted cyclic ketoenols
03/09/2005CN1589788A Modulating multiple lineage kinase proteins
03/09/2005CN1192028C Heterocyclic substituted aminoazacycles useful as central nervous system agents
03/09/2005CN1192027C Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/08/2005US6864265 Chemokine receptor binding heterocyclic compounds
03/08/2005US6864259 Antibacterial agents
03/08/2005US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders
03/08/2005US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
03/03/2005WO2005019224A2 Novel antiinfective compounds
03/03/2005WO2005019223A1 Method of manufacturing of 7-ethyl-10-[4-(1-piperidino)­-1- piperidino]- carbonyloxycamptothecin
03/03/2005WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
03/03/2005WO2004087701A8 Cyclic benzimidazoles
03/03/2005WO2004039894A3 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005US20050049413 Quinoline derivatives
03/03/2005US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
03/03/2005US20050049280 e.g., ethyl 4-(hydroxyaminocarbonyl)-4-[4-(p-trifluoromethylphenoxy)piperidin-1-ylsulfonyl]piperidine-N-carboxylate
03/03/2005US20050049278 Anticarcinogenic agents; synthesis
03/03/2005US20050049272 Gastrointestinal disorders; inhibiting gastric acid secretion; such as 2,3-dimethyl-9-(2-ethyl-6-methyl-phenyl)-7H-8,9-dihydro-pyrano[2,3-c]-imidazo[1,2-a]pyridine-6-(N,N-diethyl)carbamide
03/03/2005US20050049270 6H,11H-Indole-[3,2-C]-Isoquinoline-5-one derivatives; nuclear enzyme poly (ADP-ribose) synthetase inhibitors; inflammatory and/or reperfusion diseases
03/03/2005US20050049257 e.g., 5-[6-(dimethylamino)-4-methylpyridin-3-yl]-N-[(1R,2S)-2ethoxy-2,3-dihydro-1H-inden-1-yl]-3,6-diethylpyrazin-2-amine; used in treating anxiety disorders, depression and stress related disorders
03/03/2005US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors